Agency
Central Suffolk Hospital
Central Suffolk Hospital was paid $7.66M by Medicaid between Jan 2018 and Dec 2024, across 112 billing codes. Its largest line is 99283, emergency room visit (moderate) — 25% of everything it billed.
33Billing provider infoCENTRAL SUFFOLK HOSPITAL
RIVERHEAD, NY 11901
RIVERHEAD, NY 11901
33aNPI1386649804assigned 06/21/2005
33bProvider typeHome Health Agency
28Total paid$7.66M
24GClaims168,890
24DCodes billed112
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Home Health Agency providers in New York
Rank by total paid#515 of 851
Median peer was paid$15.00M
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official CUSACK, MICHELE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,756 | $137K | |
| 2019 | 11,489 | $513K | |
| 2020 | 25,305 | $1.07M | |
| 2021 | 35,269 | $1.48M | |
| 2022 | 30,639 | $1.49M | |
| 2023 | 35,600 | $1.61M | |
| 2024incomplete | 27,832 | $1.35M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 25% | 10,822 | 9,890 | $1.90M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 9,924 | 9,090 | $1.64M |
| 70450 | Computed tomography, head or brain; without contrast material | 8.9% | 2,423 | 2,250 | $684K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6.4% | 1,922 | 1,842 | $488K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.5% | 2,517 | 2,391 | $421K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.6% | 2,075 | 1,591 | $351K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.8% | 4,582 | 1,138 | $291K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.8% | 8,968 | 8,074 | $214K |
| 86850 | 1.7% | 3,045 | 2,920 | $133K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.5% | 1,020 | 1,013 | $115K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1.4% | 196 | 192 | $109K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.4% | 2,740 | 2,180 | $106K |
100 more codes
| 80053 | Comprehensive metabolic panel | 1.3% | 4,462 | $99K |
| 86901 | 1.3% | 3,047 | $96K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.1% | 294 | $84K |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,153 | $74K |
| 86900 | <1% | 3,047 | $70K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 245 | $66K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,577 | $64K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,454 | $63K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,447 | $59K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,060 | $54K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 751 | $49K |
| 80076 | <1% | 3,809 | $48K | |
| 87631 | <1% | 518 | $32K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 666 | $32K |
| 85610 | <1% | 5,393 | $29K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 242 | $23K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,710 | $22K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 127 | $21K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,998 | $20K |
| G0299 | Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes | <1% | 202 | $17K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 723 | $16K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 610 | $13K |
| 93975 | <1% | 14 | $9K | |
| 87486 | <1% | 258 | $9K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 13 | $8K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,893 | $7K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 90 | $7K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,836 | $7K |
| T1030 | Nursing care, in the home, by registered nurse, per diem | <1% | 79 | $6K |
| 90715 | <1% | 157 | $6K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,009 | $6K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,880 | $6K |
| 80061 | Lipid panel | <1% | 566 | $6K |
| 83880 | <1% | 177 | $5K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 210 | $5K |
| 87581 | <1% | 258 | $5K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,080 | $4K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 743 | $4K |
| 81025 | <1% | 1,178 | $4K | |
| 97161 | <1% | 39 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 163 | $3K |
| 86703 | <1% | 220 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 745 | $3K |
| 97162 | <1% | 27 | $3K | |
| 0225U | <1% | 62 | $3K | |
| 83735 | <1% | 4,243 | $2K | |
| 85730 | <1% | 5,592 | $2K | |
| 87641 | <1% | 38 | $1K | |
| 87088 | <1% | 2,670 | $1K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 17 | $1K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 381 | $1K |
| 87476 | <1% | 27 | $961.86 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 26 | $953.03 |
| 84484 | <1% | 3,051 | $885.88 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 25 | $873.94 |
| 83690 | <1% | 3,467 | $864.31 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 616 | $773.83 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 27 | $740.00 |
| 82550 | <1% | 1,935 | $698.19 | |
| 81001 | <1% | 2,766 | $690.45 | |
| 82150 | <1% | 1,741 | $634.77 | |
| 85027 | <1% | 448 | $556.07 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 811 | $520.13 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 868 | $482.64 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 25 | $468.17 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,461 | $467.93 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 20 | $429.00 |
| 81003 | <1% | 2,155 | $425.87 | |
| 82248 | <1% | 1,058 | $423.16 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 888 | $420.86 |
| 84702 | <1% | 237 | $410.61 | |
| 73630 | <1% | 109 | $396.00 | |
| 73610 | <1% | 74 | $357.83 | |
| 84703 | <1% | 3,049 | $304.64 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 114 | $273.28 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 379 | $271.29 |
| 87077 | <1% | 272 | $244.20 | |
| 96376 | <1% | 53 | $241.67 | |
| 87040 | <1% | 302 | $164.06 | |
| 84100 | <1% | 261 | $150.31 | |
| 85379 | <1% | 567 | $127.40 | |
| 82607 | <1% | 12 | $124.81 | |
| 80320 | <1% | 909 | $119.92 | |
| 84450 | <1% | 430 | $119.26 | |
| 87070 | <1% | 30 | $113.98 | |
| 87186 | <1% | 113 | $107.73 | |
| 82948 | <1% | 491 | $106.87 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 67 | $93.13 |
| 82962 | <1% | 421 | $91.67 | |
| 73130 | <1% | 44 | $74.82 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 73 | $65.24 |
| 87899 | <1% | 145 | $56.09 | |
| 83605 | <1% | 523 | $46.91 | |
| 73030 | <1% | 15 | $46.57 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 62 | $32.80 |
| 85651 | <1% | 15 | $8.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 28 | $7.08 |
| 84436 | <1% | 12 | $5.61 | |
| 76830 | Ultrasound, transvaginal | <1% | 12 | $5.47 |
| 80329 | 0% | 249 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCUSACK, MICHELE (SENIOR VICE PRESIDENT & CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.